Daily Dose - Sep 16th, 2025
Daily Dose |
View online
September 16, 2025
Lilly to build $5B manufacturing facility in Virginia, near Richmond
Part of Eli Lilly’s planned $27 billion U.S. investment, the new site will develop active pharmaceutical ingredients for cancer, autoimmune, and other advanced therapies.
Read More
Fujifilm Biosciences launches perfusion medium to support scalable viral vector production
The company has introduced a new cell culture medium designed to optimize high-density gene therapy manufacturing processes.
Read More
Abzena expands cell line platforms with GS knockout systems
The new platforms aim to improve speed and scalability in therapeutic protein development, according to the company.
Read More